Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy NeuBase Therapeutics (NBSE) stocks in Canada
Learn how to easily invest in NeuBase Therapeutics stocks.
NeuBase Therapeutics is a biotechnology business based in the US. NeuBase Therapeutics stocks (NBSE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.76 – a decrease of 3.44% over the previous week. NeuBase Therapeutics employs 33 staff and has a market cap (total outstanding stock value) of $32.3 million.
How to buy stocks in NeuBase Therapeutics
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NBSE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in NeuBase Therapeutics?
- Has coronavirus impacted NeuBase Therapeutics shares?
- NeuBase Therapeutics shares summary
- Compare share dealing platforms
- Is NeuBase Therapeutics stock a buy or sell?
- NeuBase Therapeutics performance over time
- NeuBase Therapeutics's financials
- How volatile are NeuBase Therapeutics shares?
- Does NeuBase Therapeutics pay a dividend?
- Have NeuBase Therapeutics shares ever split?
- Other common questions
NeuBase Therapeutics stock price (NASDAQ:NBSE)Use our graph to track the performance of NBSE stocks over time.
NeuBase Therapeutics shares at a glance
|Latest market close||$0.97|
|52-week range||$0.89 - $5.51|
|50-day moving average||$1.49|
|200-day moving average||$2.56|
|Wall St. target price||$13.25|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.04|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy NeuBase Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
NeuBase Therapeutics price performance over time
|1 week (2022-05-17)||-6.25%|
|1 month (2022-04-23)||N/A|
|3 months (2022-02-23)||N/A|
|6 months (2021-11-26)||-68.85%|
|1 year (2021-05-27)||-81.82%|
|2 years (2020-05-27)||-87.84%|
|3 years (2019-05-24)||3.04|
|5 years (2017-05-26)||55.74%|
NeuBase Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-54.47%|
|Return on equity TTM||-107.81%|
|Market capitalisation||$32.3 million|
TTM: trailing 12 months
NeuBase Therapeutics share dividends
We're not expecting NeuBase Therapeutics to pay a dividend over the next 12 months.
Have NeuBase Therapeutics's shares ever split?
NeuBase Therapeutics's shares were split on a 1:20 basis on 4 February 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NeuBase Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for NeuBase Therapeutics shares which in turn could have impacted NeuBase Therapeutics's share price.
NeuBase Therapeutics share price volatility
Over the last 12 months, NeuBase Therapeutics's shares have ranged in value from as little as $0.89 up to $5.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NeuBase Therapeutics's is 0.7655. This would suggest that NeuBase Therapeutics's shares are less volatile than average (for this exchange).
NeuBase Therapeutics overview
NeuBase Therapeutics, Inc. , a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania. .
Stocks similar to NeuBase Therapeutics
NeuBase Therapeutics in the news
Former White House press secretary Jen Psaki will join MSNBC this fall
NeuBase Presents New Preclinical Data at ASGCT 2022 for Its DM1 Program Demonstrating Wide Tissue Distribution and Supporting a Differentiated Whole-Body Treatment Solution
NeuBase Therapeutics presents new preclinical data at ASGCT 2022
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.Read more…
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.Read more…
More guides on Finder
Apps like Wealthsimple
Learn more about apps like Wealthsimple to find the best trading platform for your unique set of needs.
Online gaming stocks
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
How to buy Entain stock in Canada
Steps to owning and managing ENT stock, with 24-hour and historical pricing before you buy.
How to buy Kambi Group stock in Canada
Steps to owning and managing KAMBI stock, with 24-hour and historical pricing before you buy.
Best brokerage signup bonuses in 2022
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
How to buy Rush Street Interactive stock in Canada
Steps to owning and managing RSI stock, with 24-hour and historical pricing before you buy.
How to buy PointsBet stock in Canada
Steps to owning and managing PBTHF stock, with 24-hour and historical pricing before you buy.
How to buy Hanover Bancorp stock in Canada
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
How to buy Actelis Networks (ASNS) stock in Canada
Everything we know about the Actelis Networks IPO, plus information on how to buy in.